Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MXCT
- Price
- 2.04
- Stock movement up
- +0.03 (2.16%)
- Company name
- MaxCyte Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 151.38M
- Ent value
- 149.73M
- Price/Sales
- 3.32
- Price/Book
- 0.71
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 16.20%
- 1 year return
- -66.74%
- 3 year return
- -38.72%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MXCT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.32 |
| Price to Book | 0.71 |
| EV to Sales | 3.28 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 106.61M |
| EPS (TTM) | -0.34 |
| FCF per share (TTM) | -0.20 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 45.60M |
| Gross profit (TTM) | 36.04M |
| Operating income (TTM) | -46.31M |
| Net income (TTM) | -35.73M |
| EPS (TTM) | -0.34 |
| EPS (1y forward) | -0.40 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 79.04% |
| Operating margin (TTM) | -101.56% |
| Profit margin (TTM) | -78.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 36.96M |
| Net receivables | 4.56M |
| Total current assets | 172.91M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 248.61M |
| Accounts payable | 1.86M |
| Short/Current long term debt | 18.32M |
| Total current liabilities | 17.62M |
| Total liabilities | 35.31M |
| Shareholder's equity | 213.30M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -18.81M |
| Capital expenditures (TTM) | 2.42M |
| Free cash flow (TTM) | -21.23M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -16.75% |
| Return on Assets | -14.37% |
| Return on Invested Capital | -16.68% |
| Cash Return on Invested Capital | -9.91% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.37 |
| Daily high | 1.43 |
| Daily low | 1.37 |
| Daily Volume | 621K |
| All-time high | 17.20 |
| 1y analyst estimate | 6.68 |
| Beta | 0.27 |
| EPS (TTM) | -0.34 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 5 Nov 2025 |
Downside potential
Loading...
Downside potential data
| MXCT | S&P500 | |
| Current price drop from All-time high | -91.74% | -1.46% |
| Highest price drop | -92.62% | -56.47% |
| Date of highest drop | 12 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -68.68% | -10.99% |
| Avg time to new high | 205 days | 12 days |
| Max time to new high | 995 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
151.38M
Marketcap category
Small-cap
Description
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Employees
114
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page